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rhythmias in the VA-ECMO group (16% vs. 50%, p¼0.02).
CONCLUSIONS Both VA-ECMO and p-VAD had similar survival and
complication rates when used in patients presenting with RCS in AMI.
Choice of device in these patients should be based on operator
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BACKGROUND We sought to evaluate the outcomes of ECMO
in a variety of clinical settings among patients presenting in
cardiogenic shock and/or respiratory failure and underwent emer-
gent venous-arterial (VA) ECMO and/or venous-venous (VV) ECMO
placement.
METHODS We retrospectively analyzed data from 163 consecutive
ECMOs (21 VV and 142 VA) at the MH CAHF from 2012 to 2014. Mor-
tality and morbidity at discharge were analyzed in relationship to type
of ECMO support VA vs VV.
RESULTS Overall ECMO survival rates at discharge was 40%, however
signiﬁcant difference in terms of mortality and morbidity was
observed between VA and VV groups. In the VV group the median age
was 50 years (IQR 23,57), average length of stay was 33 days (IQR
22,48) median length of support was 8 days (IQR 3,20). VV mortality
was 19% (4 cases). Causes of death were stroke in 1 patient and mul-
tiorgan failure in 3 patients and death occurred after 2, 29,24,35 days,
respectively, after ECMO implantation. Respiratory failure due to
H1N1 led to ECMO implantation in 4 cases and caused the demise of 2
patients (50% mortality). No hypothermia protocol was utilized.
Vascular complications related to access were reported in 5% of the
patients. Stroke prevalence was 14% and led to patient demise in 1case. The longest length of support with successful weaning was 31
days. In the VA group the median age was 61 years (IQR 48,70),
average length of stay was days 16 days (IQR 7,34) median length of
support was 4 days (IQR 1,7). VA mortality was 65%. Refractory
cardiogenic shock was the leading indication to ECMO implantation,
however ECMO was utilized also as bailout strategy in the context of
intraprocedural complications during TAVI in 10 cases, with a 30%
mortality (3 deaths in 10 cases). Hypothermia protocols were utilized
in 20% of the cases. Stroke prevalence was 16%. The longest length of
support with successful weaning was 192 days, the oldest patient to
survive ECMO was 91 years old and median age of patients who sur-
vived ECMO was 62 years (IQR 49,70).
CONCLUSIONS This is a large data series collected from a single
center over the last two years. These results provide additional evi-
dence to support ECMO as a valid option for hemodynamic support in
patients of a selected age group presenting with profound cardiogenic
shock and respiratory failure.
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BACKGROUND Catheterization techniques can offer percutaneous
way of coronary revascularization (PCI), in complex coronary lesions.
In cath-lab we are able to perform high risk procedures, but we are
still limited with circulatory failure at time of PCI. Commercial cir-
culation supports (Impella, TandemHeart or ECMO) are expensive.
We decided to develop cheap, fully percutaneous and easy to use
way of circulatory support for backup at high risk PCI for conscious
patients.
METHODS We modiﬁed standard tubing set for open extracorporeal
circulation, we get out of the tubing kit venous reservoir and con-
nect it only for priming, deairing system and for getting volume.
Femoral artery was pre-closed by 2x ProGlide sutures and cannu-
lated with 18 F cannula, femoral vein was cannulated with 20-22 F
cannula. Blood from right atrium was drawn to the centrifugal
pump, continue to the oxygenator and through arterial ﬁlter back to
femoral artery (Image). UFH was given and circulation started at ACT
400 sec. For PCI we used contralateral groin, pressure was recorded
from sheat sideport. At the end UFH was reversed to ACT 250 sec,
arterial puncure was closed with sutures, venous with manual
compression.
